Deutsche Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35M Buy
307,797
+19,832
+7% +$2.25M 0.01% 673
2025
Q1
$30.3M Sell
287,965
-1,087
-0.4% -$114K 0.01% 729
2024
Q4
$31M Buy
289,052
+15,160
+6% +$1.62M 0.01% 742
2024
Q3
$27.4M Buy
273,892
+3,668
+1% +$367K 0.01% 760
2024
Q2
$22.8M Buy
270,224
+34,320
+15% +$2.89M 0.01% 782
2024
Q1
$17.2M Buy
235,904
+50,007
+27% +$3.66M 0.01% 852
2023
Q4
$13.3M Buy
185,897
+49,668
+36% +$3.55M 0.01% 903
2023
Q3
$8.16M Buy
136,229
+40,958
+43% +$2.45M 0.01% 901
2023
Q2
$6.87M Sell
95,271
-1,231
-1% -$88.8K ﹤0.01% 1124
2023
Q1
$7.1M Buy
96,502
+45,975
+91% +$3.38M ﹤0.01% 1096
2022
Q4
$3.38M Sell
50,527
-27,392
-35% -$1.83M ﹤0.01% 1383
2022
Q3
$4.19M Sell
77,919
-2,326
-3% -$125K ﹤0.01% 1278
2022
Q2
$4.47M Sell
80,245
-1,354
-2% -$75.4K ﹤0.01% 1345
2022
Q1
$5.73M Sell
81,599
-32,814
-29% -$2.3M ﹤0.01% 1351
2021
Q4
$11M Buy
114,413
+15,332
+15% +$1.48M 0.01% 1061
2021
Q3
$8.61M Sell
99,081
-21,301
-18% -$1.85M ﹤0.01% 1218
2021
Q2
$9.85M Sell
120,382
-12,483
-9% -$1.02M ﹤0.01% 1192
2021
Q1
$12.6M Sell
132,865
-3,507
-3% -$334K 0.01% 1080
2020
Q4
$8.46M Buy
136,372
+1,576
+1% +$97.8K 0.01% 1107
2020
Q3
$8.02M Sell
134,796
-28,748
-18% -$1.71M 0.01% 1053
2020
Q2
$11.4M Buy
163,544
+9,696
+6% +$677K 0.01% 919
2020
Q1
$6.98M Buy
153,848
+29,851
+24% +$1.35M 0.01% 1072
2019
Q4
$8.07M Buy
123,997
+28,620
+30% +$1.86M 0.01% 1200
2019
Q3
$5.92M Buy
95,377
+17,805
+23% +$1.11M ﹤0.01% 1302
2019
Q2
$5.52M Sell
77,572
-22,303
-22% -$1.59M ﹤0.01% 1746
2019
Q1
$7.83M Sell
99,875
-108,406
-52% -$8.5M ﹤0.01% 1541
2018
Q4
$17.6M Sell
208,281
-103,586
-33% -$8.77M 0.01% 954
2018
Q3
$53.4M Sell
311,867
-577,517
-65% -$98.9M 0.03% 634
2018
Q2
$115M Buy
889,384
+214,170
+32% +$27.7M 0.06% 343
2018
Q1
$69.6M Sell
675,214
-80,124
-11% -$8.25M 0.03% 518
2017
Q4
$64.5M Sell
755,338
-68,029
-8% -$5.81M 0.04% 452
2017
Q3
$69.9M Sell
823,367
-92,053
-10% -$7.82M 0.05% 424
2017
Q2
$69.3M Sell
915,420
-14,508
-2% -$1.1M 0.05% 428
2017
Q1
$61.4M Buy
929,928
+114,209
+14% +$7.54M 0.05% 436
2016
Q4
$51.7M Buy
815,719
+66,512
+9% +$4.22M 0.04% 482
2016
Q3
$47.7M Buy
749,207
+37,318
+5% +$2.38M 0.03% 539
2016
Q2
$53M Sell
711,889
-11,633
-2% -$866K 0.04% 500
2016
Q1
$48.3M Buy
723,522
+95,848
+15% +$6.4M 0.04% 512
2015
Q4
$42.5M Sell
627,674
-6,405
-1% -$433K 0.03% 583
2015
Q3
$33.9M Buy
634,079
+133,909
+27% +$7.15M 0.03% 630
2015
Q2
$31.5M Sell
500,170
-2,766
-0.5% -$174K 0.02% 719
2015
Q1
$24.2M Sell
502,936
-24,236
-5% -$1.17M 0.02% 827
2014
Q4
$17.5M Sell
527,172
-50,993
-9% -$1.69M 0.01% 1077
2014
Q3
$16.9M Buy
578,165
+439,988
+318% +$12.9M 0.01% 1016
2014
Q2
$5.37M Buy
138,177
+32,748
+31% +$1.27M ﹤0.01% 1756
2014
Q1
$4.42M Sell
105,429
-94,019
-47% -$3.95M ﹤0.01% 1905
2013
Q4
$6.54M Sell
199,448
-473,115
-70% -$15.5M ﹤0.01% 1580
2013
Q3
$18.2M Sell
672,563
-33,980
-5% -$917K 0.01% 945
2013
Q2
$16.5M Buy
+706,543
New +$16.5M 0.01% 953